Safety, Immunogenicity, and Immune Memory of a Novel Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (MCV-4) in Healthy Adolescents

This publication has 13 references indexed in Scilit:

• Comparative Trial of the Safety and Immunogenicity of Quadrivalent (A, C, Y, W-135) Meningococcal Polysaccharide-Diphtheria Conjugate Vaccine Versus Quadrivalent Polysaccharide Vaccine in Two- to Ten-Year-Old Children
  The Pediatric Infectious Disease Journal, 2005
• Effects of Prior Polysaccharide Vaccination on Magnitude, Duration, and Quality of Immune Responses to and Safety Profile of a Meningococcal Serogroup C Tetanus Toxoid Conjugate Vaccination in Adults
  Clinical and Vaccine Immunology, 2004
• Bacterial Meningitis — A View of the Past 90 Years
  New England Journal of Medicine, 2004
• Clinical Features and Prognostic Factors in Adults with Bacterial Meningitis
  New England Journal of Medicine, 2004
• Opportunities for Control of Meningococcal Disease in the United States
  Annual Review of Medicine, 2004
• Safety, Reactogenicity, and Immunogenicity of a Tetravalent Meningococcal Polysaccharide–Diphtheria Toxoid Conjugate Vaccine Given to Healthy Adults
  The Journal of Infectious Diseases, 2002
• Antibody Persistence and Immunological Memory at Age 4 Years after Meningococcal Group C Conjugate Vaccination in Children in the United Kingdom
  The Journal of Infectious Diseases, 2002
• Standardisation and Validation of Serological Assays for the Evaluation of Immune Responses to Neisseria meningitidis Serogroup A and C Vaccines
  Biologicals, 2000
• The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996
  The Journal of Infectious Diseases, 1999
• Risk of meningococcal infection in college students.
  JAMA, 1999